Atara Biotherapeutics EV - Enterprise Value 2011-2026 | ATRA

Annual EV - Enterprise Value Atara Biotherapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
232 M	242 M	676 M	1.56 B	1.38 B	676 M	1.58 B	1.16 B	326 M	449 M	102 M	11.2 M	3.81 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.58 B	3.81 M	646 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
ADMA Biologics ADMA	3.84 B	$ 16.49	-0.3 %	$ 3.93 B	USA
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
AbCellera Biologics ABCL	1.22 B	$ 3.59	-1.1 %	$ 1.07 B	Canada
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
AlloVir ALVR	-64.1 M	-	4.14 %	$ 49.1 M	USA
Apellis Pharmaceuticals APLS	3.01 B	$ 20.5	3.22 %	$ 2.59 B	USA
Aptorum Group Limited APM	9.45 M	$ 0.81	-1.57 %	$ 4.42 M	China
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
ANI Pharmaceuticals ANIP	1.91 B	$ 75.14	-1.82 %	$ 1.45 B	USA
Applied Therapeutics APLT	563 M	-	-	$ 8.42 M	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Autolus Therapeutics plc AUTL	1.11 B	$ 1.57	-3.68 %	$ 401 M	Britain
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Athersys ATHX	-37.4 M	-	3.77 %	$ 22.4 M	USA
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
AVEO Pharmaceuticals AVEO	86.9 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	8.95 B	$ 163.09	-0.61 %	$ 8.11 B	USA
Champions Oncology CSBR	125 M	$ 6.0	-	$ 82 M	USA
BridgeBio Pharma BBIO	15.5 B	$ 65.5	-1.57 %	$ 12.5 B	USA
Brainstorm Cell Therapeutics BCLI	15.7 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	-9.74 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	115 M	-	-7.31 %	$ 87 M	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
Bellerophon Therapeutics BLPH	77.1 M	-	-74.18 %	$ 955 K	USA
BioLineRx Ltd. BLRX	15 M	$ 2.84	1.07 %	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	11.9 B	$ 60.3	-0.22 %	$ 11.6 B	USA
Burford Capital Limited BUR	3.22 B	$ 8.34	-0.48 %	$ 1.36 B	Britain
Cabaletta Bio CABA	-155 M	$ 3.37	-1.75 %	$ 3.94 M	USA
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	-75.9 M	$ 3.04	-5.0 %	$ 1.09 M	USA
Galmed Pharmaceuticals Ltd. GLMD	2.36 M	$ 0.59	-	$ 549 K	Israel
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Capricor Therapeutics CAPR	177 M	$ 25.56	0.22 %	$ 684 M	USA